Literature DB >> 21407778

Properdin System in Infections and in Malignant Blood Dyscrasias.

P A Bunn, A L Baltch.   

Abstract

Entities:  

Year:  1959        PMID： 21407778      PMCID： PMC2249131     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  5 in total

1.  Serum-properdin levels in patients with Hodgkin's disease and carcinoma.

Authors:  A ROTTINO; A L LEVY
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

2.  Studies on the inactivation of phage by the properdin system. II. Quantitative assay of phage-neutralizing activity.

Authors:  J L BARLOW; H VAN VUNAKIS; L LEVINE
Journal:  J Immunol       Date:  1958-05       Impact factor: 5.422

3.  Studies of the inactivation of phage by the properdin system. I. Evidence for complement, properdin and magnesium requirements.

Authors:  J L BARLOW; H VAN VUNAKIS; L LEVINE
Journal:  J Immunol       Date:  1958-05       Impact factor: 5.422

4.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

5.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.